Packing Materials Selection Recommendation Guide
Application | Purification Step | Separation Mode | Recommended Packing Material |
---|---|---|---|
Semaglutide (Fermentation) | Pretreatment | Reverse Phase |
Sunnasil-CH C18 30-300/120 (P/N: CH9302000-2)
|
Primary Purification | Reverse Phase |
Sunnasil-BS C18 plus 8-100 (P/N: BS9082000-0) Sunnasil-BS C18 pro 10-120 (P/N: BSE082000-2) Sunnasil-CH C18 10-120 (P/N: CH9102000-0)
|
|
Secondary Purification | Reverse Phase |
Sunnasil-BS C18 pro 10-120 (P/N: BSE082000-2) Sunnasil-BS C18 plus 8-100 (P/N: BS9082000-0)
|
|
Salt Conversion | Reverse Phase |
Sunnasil-CH C8 30-300
(P/N: CH8302000-LA)
|
|
Semaglutide (Synthetic) | Primary Purification | Reverse Phase |
Sunnasil-HS C8 pro 10-100 (P/N: HST102000-0) Sunnasil-BS C18 plus 8-100 (P/N: BS9082000-0)
|
Secondary Purification | Reverse Phase |
Sunnasil-BS C18 pro 10-120 (P/N: BSE082000-2) Sunnasil-BS C18 plus 8-100 (P/N: BS9082000-0)
|
|
Salt Conversion | Reverse Phase |
Sunnasil-CH C8 30-300
(P/N: CH8302000-LA)
|
|
Semaglutide-29 Peptide | Single-Step Purification | Reverse Phase |
Sunnasil-CH C18 10-120 (P/N: CH9102000-0) Sunnasil-HS C18 10-100 (P/N: HS9102000-0)
|
Tirzepatide | Primary Purification | Reverse Phase |
Sunnasil-HS C8 pro 10-100 (P/N: HST102000-0) Sunnasil-BS C18 plus 8-100 (P/N: BS9082000-0)
|
Secondary Purification | Reverse Phase |
Sunnasil-BS C18 pro 10-120 (P/N: BSE082000-2) Sunnasil-BS C18 plus 8-100 (P/N: BS9082000-0)
|
|
Salt Conversion | Reverse Phase |
Sunnasil-CH C8 30-300
(P/N: CH8302000-LA)
|
|
Liraglutide | Single-Step Purification | Reverse Phase |
Sunnasil-HS C8 10-100 (P/N: HS8102000-0) Sunnasil-HS C8 pro 10-100 (P/N: HST102000-0)
|
Retatrutide | Reverse Phase |
Sunnasil-HS C8 pro 10-100 (P/N: HST102000-0) Sunnasil-BS C18 pro 10-120 (P/N: BSE082000-2) Sunnasil-BS C18 plus 8-100 (P/N: BS9082000-0)
|
|
Thymalfasin | Reverse Phase |
Sunnasil-BS C18 pro 10-120 (P/N: BSE082000-2)
|
|
Etelcalcetide | Reverse Phase |
Sunnasil-BS C18 10-120 (P/N: BS9102000-2)
|
|
Short Peptides | Reverse Phase |
Sunnasil-BS AQ C18 10-100 (P/N: BSM102000-0) Sunnasil-BS HILIC 10-100
(P/N: CH8302000-LA)
|
|
Insulin | Reverse Phase |
Sunnasil-HS C8 10-100 (P/N: HS8102000-0)
|
|
Cyclosporine | Normal Phase |
Sunnasil-BS Silica 30-120 (P/N: BSS302000-2)
|
|
Ifosfamide | Normal Phase |
Sunnasil-BS Silica 30-120 (P/N: BSS302000-2)
|
|
Orlistat | Normal Phase |
Sunnasil-BS Silica 15-120 (P/N: BSS152000-2) Sunnasil BS C18 10-120 (P/N: BS9102000-2)
|
|
Coenzyme Q10 | Reverse Phase |
Sunnasil-BS C18 30-120
(P/N: CH8302000-LA)
|
|
EPA Monomer | Reverse Phase |
Sunnasil-BS AQ C18 10-120 (P/N: BSM102000-2)
|
|
ADC Drugs | Reverse Phase |
Sunnasil-BS C18 pro 10-120 (P/N: BSE082000-2) Sunnasil-BS C18 plus 8-100 (P/N: BS9082000-0)
|
|
Small Nucleic Acid Drugs | Reverse Phase |
Sunnasil-BS C18 10-120 (P/N: BS9102000-2) Sunnasil-BS C18 pro 10-120 (P/N: BSE082000-2) Sunnasil-BS C18 plus 8-100 (P/N: BS9082000-0)
|
|
Antibiotics | Reverse Phase |
Sunnasil-HS C18 10-100 (P/N: HS9102000-0) Sunnasil-BS C18 10-120 (P/N: BS9102000-2)
|